Search

Search Constraints

You searched for: Author/Creator Kuzel, Timothy M

Search Results

1. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Issue 10032 (14th May 2016)

2. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Issue 10094 (5th August 2017)

3. FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy. Issue 11 (3rd November 2022)

5. Sebaceous carcinoma: evidence-based clinical practice guidelines. Issue 12 (December 2019)

6. The effects of the order of multiple imputation in subset analysis examining the association between body mass index (BMI) and transrectal ultrasound prostate weight. (6th July 2016)